Cabaletta Bio Inc logo

Cabaletta Bio Inc

1
NAS:CABA (USA)   Ordinary Shares
$ 17.14 +0.19 (+1.12%) 11:09 PM EST
At Loss
P/B:
3.37
Market Cap:
$ 826.86M
Enterprise V:
$ 581.95M
Volume:
773.93K
Avg Vol (2M):
960.57K
Also Trade In:
Volume:
773.93K
At Loss
Avg Vol (2M):
960.57K

Business Description

Cabaletta Bio Inc logo
Cabaletta Bio Inc
NAICS : 325412 SIC : 2834
ISIN : US12674W1099

Share Class Description:

CABA: Ordinary Shares
Description
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) has the potential to be applied across a broad range of autoimmune diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 48.08
Equity-to-Asset 0.93
Debt-to-Equity 0.02
Debt-to-EBITDA -0.07
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 25.8
9-Day RSI 26.03
14-Day RSI 30.78
6-1 Month Momentum % 65.44
12-1 Month Momentum % 222.97

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 15.29
Quick Ratio 15.29
Cash Ratio 15.08

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -24.4
Shareholder Yield % -11.49
Name Current Vs Industry Vs History
ROE % -44.09
ROA % -40.67
ROIC % -559.01
ROC (Joel Greenblatt) % -1077.13
ROCE % -47.98

Financials (Next Earnings Date:2024-05-10 Est.)

CABA's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CABA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Cabaletta Bio Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.66
Beta 3.13
Volatility % 54.35
14-Day RSI 30.78
14-Day ATR ($) 1.328671
20-Day SMA ($) 19.839
12-1 Month Momentum % 222.97
52-Week Range ($) 6.94 - 26.35
Shares Outstanding (Mil) 48.24

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cabaletta Bio Inc Filings

Filing Date Document Date Form
No Filing Data

Cabaletta Bio Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Cabaletta Bio Inc Frequently Asked Questions

What is Cabaletta Bio Inc(CABA)'s stock price today?
The current price of CABA is $17.14. The 52 week high of CABA is $26.35 and 52 week low is $6.94.
When is next earnings date of Cabaletta Bio Inc(CABA)?
The next earnings date of Cabaletta Bio Inc(CABA) is 2024-05-10 Est..
Does Cabaletta Bio Inc(CABA) pay dividends? If so, how much?
Cabaletta Bio Inc(CABA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1